Connect with us

US

Lung Cancer Survivors On Long Island Rave About Immunotherapy, Which Doctors Say Is Akin To A Cure For Some

Published

on

[ad_1]

MINEOLA, NY (CBSNewYork) – The blast of the moon was gathered on Long Island. Remains lung cancer celebrated.

Formerly thought to be incurable, advances in treatment contribute to years of quality of life, and in some cases, patients are now cancer-free, CBS2’s Carolyn Gusoff told reporters.

READ MORE: Kathy Griffin Announces Lung Cancer

Bells are ringing to celebrate life, including the life of 55-year-old Christina Lamarca, who remembered the prognosis of her delayed heart with stage 4 lung cancer.

“I live three months,” said Lamarca.

that was five years ago. She was then enrolled in the clinical trial immunotherapy at NYU Perlmutter Cancer Center and meet her grandchildren.

“Life is worth living. I’m going to go. I won’t go anywhere,” said Lamarca.

Janeen Johnson-Gall, a mother of five, also received a desperate diagnosis.

“In the back of my mind, oh my God, it’s my opinion,” Johnson-Rooster said.

She also was in therapeutics of sorties. Ten participants in the Mineola trial were collected as a living proof that they can survive with advanced lung cancer, the most lethal of all cancers.

“We have several such patients who are presented today, essentially, with a death sentence,” said Jeffrey Schneider of the Perlmutter Cancer Center.

READ MORE: Federal Task Force Expands Screening Recommendations to Include Current and Former Smokers Ages 50-80

Immunotherapy is antibody.

“The treatments by which the body’s immune system enables it to recognize and eradicate cancer. So, we’re really just pushing our defense against poisons to kill cancer,” Schneider said.

Lung cancer is the leading cancer killer in the U.S., with a quarter of a million Americans diagnosed each year. Immunotherapy increases survival by more than five years.

Frank Crescentio, one of the first to be in the process, is celebrating 11 years, giving time to watch his growing grandchildren.

“It is great, it is great,” said Crescentius.

“It is wonderful,” he added to his wife, Nancy.

Immunotherapy doesn’t work at all, but doctors say that in 20% of cases, it is linked to a cure. Next 80% may experience second generation treatment.

“I’m ringing the bell, very hopeful about the future,” said Johnson-Rooster.

They were celebrating their lives and the health of the workers so that it could be done.

MORE NEWS: International Studies on New Lung Cancer Screenings Can Reduce Mortality By 20%

Immunotherapy is now approved for the treatment of lung cancer, and no longer are patients enrolled in the clinical trial to receive treatment.

.

[ad_2]